pharmaceutical compositions are disclosed for the treatment of nicotine dependence or addiction , tobacco dependence or addiction , reduction of nicotine withdrawal symptoms or aiding in the cessation or lessening of tobacco use or substance abuse . the pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotine receptor partial agonist and an anti - depressant or anxiolytic agent and a pharmaceutically acceptable carrier . the method of using these compounds is also disclosed .